FCS leaders showcase innovative solutions and expert insights at the COA 2026 Community Oncology Conference to advance high-quality, community-based cancer care.
Florida Cancer Specialists & Research Institute partners with Research to Practice to host the 5th Annual National General Medical Oncology Summit, where leading experts share cutting-edge data, emerging treatments and collaborative insights to advance personalized cancer care in community settings.
Learn how innovative bispecific antibody therapy treatment works through the FCS’s bispecific maintenance program and how it helps the immune system better recognize and attack cancer cells.
Learn the basics of bispecific antibody therapy and what patients can expect during step-up dosing treatment at Florida Cancer Specialists & Research Institute.
Florida Cancer Specialists & Research Institute leaders present specialty pharmacy operations, dispensing and patient navigation best practices at the NCODA 2026 Spring Forum, highlighting innovations that improve access, patient experience and clinical outcomes in oncology care.
Ultra-processed foods: villain or misunderstood? Nutrition expert Nadine Pazder explores the facts behind UPF and provides guidance on how to make informed food choices for a healthier lifestyle.
Learn the truth about sugar and cancer. Discover evidence-based nutrition guidelines and why eliminating all sugar isn’t necessary for cancer patients.
Wherever you live, it’s important to have a disaster preparedness plan. It’s especially important in Florida, where hurricane season is officially June 1 to November 30.
FCS Leaders Spotlight Innovation and Collaboration at COA 2026 to Advance Community Oncology CareFCS leaders showcase innovative solutions and expert insights at the COA 2026 Community Oncology Conference to advance high-quality, community-based cancer care.
FCS Advances Oncology Care Through Expert Collaboration and Innovative Exchange at Exclusive EventFlorida Cancer Specialists & Research Institute partners with Research to Practice to host the 5th Annual National General Medical Oncology Summit, where leading experts share cutting-edge data, emerging treatments and collaborative insights to advance personalized cancer care in community settings.
Bispecific Therapy MaintenanceLearn how innovative bispecific antibody therapy treatment works through the FCS’s bispecific maintenance program and how it helps the immune system better recognize and attack cancer cells.
FCS Highlights Leadership in Advancing Medically Integrated Oncology CareFlorida Cancer Specialists & Research Institute leaders present specialty pharmacy operations, dispensing and patient navigation best practices at the NCODA 2026 Spring Forum, highlighting innovations that improve access, patient experience and clinical outcomes in oncology care.
FCS Contributes to Milestone that Expands Treatment Options For Patients With Recurrent Ovarian CancerFDA approves KEYTRUDA for certain hard-to-treat ovarian cancers, with research support from FCS improving outcomes.
FCS Joins Oncology Leaders to Help Shape the Future of Cancer Care at FLASCO 2026FCS joins oncology leaders at FLASCO 2026 to share insights on workforce transformation and innovative care models shaping the future of cancer care.
FCS Phase 3 Trial Demonstrates Initial Clinical Benefit of Novel Immunotherapy For Advanced Non-Small Cell Lung CancerFCS contributes to PRESERVE-003 findings showing gotistobart may improve outcomes in metastatic NSCLC.
